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The current target of elimination as a
public health problem (EPHP) for lym-
phatic ﬁlariasis was originally devised
with the intention of interrupting trans-
mission. However, some countries that
have achieved EPHP are still ﬁnding
new cases.
Analysis of the evidence for key biological
determinants suggests that a target
threshold of b1% microﬁlaria (mf) preva-In the global drive for elimination of lymphatic ﬁlariasis (LF), 15 countries have
achieved validation of elimination as a public health problem (EPHP). Recent empir-
ical evidence has demonstrated that EPHP does not always lead to elimination of
transmission (EOT). Here we show how the probability of elimination explicitly de-
pendson key biological parameters,manyofwhich havebeenpoorly characterized,
leading to a poor evidence base for the elimination threshold. As more countries
progress towards EPHP it is essential that this process is well-informed, as prema-
turely halting treatment and surveillance programs could pose a serious threat to
global progress. We highlight that reﬁnement of the weak empirical evidence base
is vital to understand drivers of elimination and inform long-term policy.lence is not likely to be sufﬁcient for trans-
mission interruption in communities with
a mid-to-high annual biting rate.
The experimental evidence underlying
estimates is insufﬁcient or inconsistent,
particularly transmission rates from vec-
tor to human, leading to high uncertainty
in conﬁdence of elimination success.
Local biting rate is expected to be highly
variable between settings and could
have a large impact on elimination feasi-
bility for a given target prevalence.
Further experimental studies are needed
to reﬁne our understanding of LF elimina-
tion thresholds.
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(E.L. Davis).Global Situation and Progress
There are currently 886 million people across 52 countries worldwide at risk of LFi. Infection is
caused by a mosquito-transmitted ﬁlarial worm and, if left untreated, can lead to permanent
and debilitating disability. The Global Program to Eliminate Lymphatic Filariasis (GPELF) set a
target of elimination as a public health problem (EPHP) (see Glossary) in 1997, leading to
over 7.1 billion treatments delivered as part of mass drug administrations (MDAs) since
2000i. In 2011, the WHO published guidelines for halting treatment and verifying EPHP through
the use of transmission assessment surveys (TAS) to measure a target thresholdii,iii. By
October 2018, 14 countries had reached this target, and 554 million people worldwide no longer
require mass treatmentsiv.
As indicated by the name of the TAS, it was hoped that reaching these targets would lead to elim-
ination of transmission (EOT) in most areas. However, in Sri Lanka the TAS has been demon-
strated as not sensitive enough to detect low-level persistence [1,2], and pockets of
transmission are still being found despite EPHP validation. The community is now revisiting the
TAS methods, including the original target of 1% microfilaria (mf) prevalence [3], particularly
in the context of the new triple-drug regimen which is hoped to accelerate progress, but will
require different post-treatment surveillance [4].
It is possible that achieving EPHP, according to the current deﬁnition, will lead to EOT in some
settings [5,6], but the high levels of variability between localities, and uncertainty in our knowledge
of transmission, make it hard to predict where this will occur. This is exacerbated further by
seasonal variation in environmental conditions, which has been shown to impact a number of hel-
minth infections [7,8]. Residual infection remaining after MDA cessation can lead to resurgence
and reintroduction [9,10], with long-term persistence dependent on a range of factors [11].
Sexual Reproduction in the Host, and Elimination
The sexual reproduction of ﬁlarial worms requires both male and female parasites to be present in
an individual host for microﬁlariae production, so at a sufﬁciently low prevalence we would expectTrends in Parasitology, Month 2019, Vol. xx, No. xx https://doi.org/10.1016/j.pt.2019.08.003 1
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Glossary
Annual biting rate (ABR): the average
number of mosquito bites per person
per year.
Basic reproductive number (R0): the
average number of new infectious cases
generated by one infectious case in an
entirely susceptible population.
Blood feeding rate (BFR): the rate at
which mosquitoes take a blood meal.
Branching process: a stochastic
process which consists of collections of
random variables, which are indexed by
the natural numbers (1,2,3,…).
Breakpoint: a prevalence level below
which sustained transmission is not
viable and elimination (zero cases)
becomes an absorbing state.
Effective reproductive number (Re):
the average number of new infectious
cases generated by one infectious case
in a population made up of both
susceptible and infectious hosts.
Elimination as a public health
problem (EPHP): as measured by
TAS, a metric used by the WHO to
validate programme success. Intended
to naturally lead to EOT.
Extrinsic incubation period (EIP): the
time it takes for ingested mf to develop
to infectious L3 larvae in the mosquito.
Implementation unit: the designated
level of the administrative unit in a
country, for which the decision to
administer antiﬁlarial drugs to the entire
population is taken if it is identiﬁed as
having indigenous transmission or
endemicity.
L3: the third larval stage of the parasite;
at this point it is infectious to humans.
Mass drug administration (MDA):
the administration of drugs to a whole
population, irrespective of disease status.
Microfilaria (mf): developmental
stages in the bloodstream, produced by
fertilized female worms, that can be
picked up by mosquitoes.
Transmission assessment surveys
(TAS): a series of surveys designed by
the WHO to measure post-MDA
infection levels and verify EPHP.
Triple drug: ivermectin and
diethylcarbamazine and albendazole
(IDA): a drug combination that has
recently become the gold standard for
treatment of LF.
Univariate: literally 'of one variable'.
Univariate analysis explores variables
one-by-one, keeping all others ﬁxed.
Vector–host ratio: the number of
vectors per human in a geographical
region.
(A) Breakpoint exncon
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Trends in Parasitology
Figure 1. Lymphatic Filariasis Extinction Theory. Schematics comparing the theory behind breakpoint extinction (A) and
stochastic extinction (B) for lymphatic ﬁlariasis. (A) For sufﬁciently low transmission intensities (i.e., low biting rates), disease levels
will drop away to zero. Beyond the critical transmission level (black broken line) there are three equilibria: high disease (stable
red), low disease (unstable 'breakpoint', green), disease-free (stable, black). Disease levels above the breakpoint will increase
(Figure legend continued at the bottom of the next page.
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Trends in Parasitologymost infections to be nontransmissible due to low parasite load (i.e., a low probability of male and
female adults in the same host). This is expected to result in fewer onward infections, and hence
increasingly lower prevalence and intensity, until infection dies out. The threshold belowwhich we
expect this phenomenon to occur is called the breakpoint [12,13]. As the focus of some
neglected tropical disease (NTD) programs has shifted from control towards elimination, there
have been a number of studies aiming to quantify these thresholds for a variety of helminth
infections within the NTD umbrella [14–17].
This theory has certain consequences for control (Figure 1A). If transmission is sufﬁciently low,
then the infection is expected to die out. If there is a higher transmission rate, outcomes depend
on the mean worm load in the population; if, usually through control strategies, the worm load is
below the green broken line (the breakpoint) then elimination is assured. Previous modelling
studies that have assessed breakpoint thresholds have found values of much less than 1% mf
prevalence [10,18–20]. It has been previously demonstrated that factors such as parasite aggre-
gation and vector competence will further affect these thresholds [21], and the majority of studies
have focused on speciﬁc geographical areas, resulting in a wide range of suggested breakpoints
across the literature.
Measuring breakpoints that are substantially lower than 1% mf prevalence would require infeasi-
ble sample sizes and survey costs. In this review we do not argue for a speciﬁc breakpoint, in-
stead focusing on asserting that the experimental evidence is too uncertain to conclusively
support a 1% threshold and emphasizing the importance of spatial heterogeneity.
Whilst breakpoint theory is extremely useful, it is also possible for stochastic, or chance, extinction
to occur before this breakpoint is reached, particularly when infection levels are low (Figure 1B).
The probability of elimination, given a particular prevalence (e.g., 1%), can be calculated by
considering the probability that a chain of transmission will die out (in mathematics we call this
chain a branching process [22]). These types of branching process methods have been used
for soil-transmitted helminths [23,24], but have been adapted here to account for vector-borne
transmission with an aggregated bite risk [25,26].
Current guidelines mean that EPHP is validated after passing TAS, but we have little experience in
what this means for long-term transmission. Assuming for simplicity that TAS is able to measure a
true mf prevalence of less than 1%, this theory of stochastic extinction can be used to estimate
how the future probability of EOT (zero cases) depends on a range of setting- and disease-
speciﬁc variables. This process uses the distribution of the number of infectious secondary
cases caused by one infectious individual, the mean of which is the effective reproductive
number (Re).
As a toy example, for a population of 1000 and 1% mf prevalence, we consider a distribution of
individual worm burdens (Figure 2A). Infections with only one worm are nontransmissible. From
one infectious person you then get the number of new cases, Z, caused during their infectious
period (Figure 2B). Since transmission represents a chance event, Z is best represented by a
distribution, and acts as a proxy for Re. This distribution determines the probability of the
transmission chain dying out, that is, no further cases, at some point in the future; for more detailto the higher equilibrium,whereas disease levels belowwill decrease to zero. (B) Visual depiction of a branching process starting
with one infectious individual. The number of secondary infections caused by each currently infectious individual are sampled
from the secondary case distribution. This is used to simulate the onward chains of infection; extinction occurs when al
chains die out (i.e., have no secondary cases). Stochastic variation can cause this to occur even above the theoretica
breakpoint threshold.
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Figure 2. Simulating Branching Process Extinction. A schematic describing the simulation process for calculating
the number of secondary cases produced by one infectious individual in a population with 1% microﬁlaria (mf) prevalence
(A) Allocate distribution of adult worms and bite risks across the population. Individuals with 1 worm are infected but are
not infectious, individuals with two or more worms are considered potentially infectious. (B) Generational calculation o
number of new infectious cases caused by one infectious individual. One infectious individual infects X vectors. The
vectors that survive the incubation take infectious blood meals, resulting in Y new adult worms. These worms are distributed
across the population according to bite risk aggregation, resulting in Z new infectious (≥2 worms) individuals.
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fsee Box S1 in the supplemental information online. We use this to give a univariate demonstra-
tion of the present parameter uncertainty and how this might impact two epidemiological mea-
sures: the probability of elimination and the effective reproductive number.
Empirical Evidence for Life-Cycle Variables
We now review evidence for key parameters in the life cycle which drive transmission (Figure 3).
As previously mentioned, a number of these variables, such as the annual biting rate (ABR),
are likely to introduce large differences due to the high spatial variability. Others, such as the prob-
ability an infectiousmosquito bite results in a viable human infection, have the potential to bemore
consistent across settings, but currently lack in experimental evidence.
Probability infecous
Probability bite on
ABR
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Figure 3. Lymphatic Filariasis Life-cycle. Life-cycle schematic demonstrating key biological variables that could affec
prediction of elimination success. Duration of infection is determined by human and fecund worm lifespans. Infection from
host to vector depends on the annual biting rate (ABR) and the probability that a bite on an infectious host infects a vector
The number of vectors that survive to infectivity depends on the extrinsic incubation period (EIP) and vector lifespan
Transmission from vector to host is then determined by the blood feeding rate and the probability that an infectious bite
results in a viable adult infection, as well as the requirement for two or more worms for infectivity.
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.A detailed literature review turns up widely varying estimates of ABR, partially due to geographical
variation. These values, from countries with a history of LF endemicity, range from three [27] to
611 [28] bites per person per day. A number of these are based on human landing catches
[27–29], with the majority relying on studies from the 1960s and 1970s [28], whilst some are de-
rived from models [30]. Despite a wealth of historic studies, supported by the malaria literature,
human landing catches are often considered unethical and give highly variable results. Relying
on historic estimates can also disregard changes in socioeconomic conditions resulting in
decreased vector–human contact.
Current estimates in the literature of the basic reproductive number, R0, range from zero to
2.5 [31], depending on the vector–host ratio (an alternative metric to ABR). Although setting-
speciﬁc values of R0 for other diseases can often be calculated from infection data, the global
landscape of public health history for LF means that we have very little contemporary baseline
(precontrol) data with which to do this. As an alternative, we can consider the previously
mentioned estimation of Re.s in Parasitology, Month 2019, Vol. xx, No. xx 5
Trends in ParasitologyAnother important, but largely uncertain, factor is the degree of parasite aggregation, measured
inversely by the negative binomial k. For LF, adult worm aggregation is considered to be driven by
heterogeneous transmission, caused by host variation in bite risk [15]. Initial estimates for k were
based onmf data (k = 0.08, 0.3 [21,26]). However, a recent study in Papua NewGuinea used bite
and mf data to demonstrate that the k for bite risk is an order of magnitude larger than that for mf
aggregation, giving a reﬁned estimate of 0.73 (standard deviation 0.035), with site-speciﬁc esti-
mates ranging from 0.3 to 1.3 [15,26]. We will now separate transmission into two parts: humans
to mosquitoes, and mosquitoes to humans. When considering the former, the key variables are
duration of infection, which depends on fecund worm lifespan, and the probability that a vector
biting an infected host will become infectious.
Often worm lifespan is stated as being 6–8i or 5–10 years [32,33], but reference trails rarely reveal
empirical evidence. There are studies that corroborate similar ranges, such as 2.1–5.4 [34] or
9.1–11.8 [35] years, but there are also estimates in the literature of up to 40 years [36].
Infectivity to mosquitoes depends on mf intensity, leading to wide ranges of 15–60% of vectors
becoming infected from a single mf-positive bite [37,38].
Infection from vector to human is governed by the number of infectious bloodmeals onemosquito
will take – calculated from vector survival and competence, extrinsic incubation period (EIP)
and blood feeding rate (BFR) – and the probability one infectious bite will result in a viable infec-
tion. There are reasonable estimates for vector survival and BFR from themalaria literature [27,39]
and for LF incubation [40], although these do not typically account for the impact of infection on
survival [37].
One key parameter of infection, the probability an infectious bite results in a mature human infec-
tion, is largely unknown. Estimates range from 10–5 to 10–3 [41,42] and are usually broken down
into three steps: the L3 leaving the vector, entering the host, and developing to fecundity. The ﬁrst
step is relatively straightforward to measure [43], although it poses ethical issues, and the second
can be estimated using mouse models [44,45]. The third is harder; best estimates are calculated
by usingBrugia malayi studies to derive a daily death rate and then applying this across the longer
Wucheria bancrofti developmental period [32,46].
Quantifying the Probability of Elimination
If we include these parameters in the simple framework described above, we can see how the
uncertainty affects our estimates of key epidemiological measures (Figure 4). The mid-points of
elimination probability (0.73) and Re (1.1) are not intended to be true estimates, rather they repre-
sent a mid-ground of the parameter ranges found in the literature and a basis for comparison.
The variable which generates the most univariate uncertainty is the probability that an infectious
mosquito bite will infect a human, b, due to the wide range of possible values. Variation in
elimination probability due to ABR, which is correlated with the basic reproductive number (R0),
is also very high. This is due to both measurement inaccuracy and spatiotemporal variability.
Parameters that are known to be key drivers in the probability of elimination, worm fecund lifespan
and the degree of adult worm aggregation [21,47,48], potentially induce lower uncertainty here
due to considering narrower plausible intervals.
In addition to the probability of elimination, we also consider the effective reproductive number,
Re. It is important to note that, for helminth infections, metrics often refer to the number of adult
ﬁlarial worms arising from one adult ﬁlarial worm, rather than considering human cases. However,6 Trends in Parasitology, Month 2019, Vol. xx, No. xx
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Outstanding Questions
How can we translate our understanding
of elimination dynamics to clear and
feasible guidelines for public health
programs?
Is there a universal threshold, or do we
need to tailor predictions for different
communities and settings?
What are the key determinants that
vary between settings, and how can
we measure them?
How can we reliably measure annual
biting rate for different settings?
How can we reﬁne our estimates of
transmission probability from vectors
to humans?
How can we determine where 1% mf
prevalence is a threshold below which
elimination is likely?
If lower target thresholds are required
for elimination of transmission, then
are we realistically able to measure
these using current tools?
Whilst we can measure that prevalence
is below certain thresholds, is this
sufﬁcient evidence of elimination of
transmission?
In settings where we are still seeing
new cases after EPHP veriﬁcation,
what is the probability of large-scale
resurgence?
What is a suitable survey design in a
context of limited resources?
How will the new diagnostic affect
elimination measurement?
How can we harness xeno-monitoring
techniques to improve post-EPHP
surveillance?
Trends in Parasitologythe theory is similar enough to allow heuristic comparison. Ourmid-estimate forRe is chosen to be
close to 1, representative of the low-level transmission observed in some post-MDA settings, but
varying the probability that an infectious mosquito bite will lead to a patent infection (b) can lead to
an order of magnitude difference. In fact, it is possible to push the estimate ofRe across the critical
threshold (Re = 1) between extinction and endemicity by adjusting any variable within the ranges
found in the literature. This reinforces the importance of using reliable variable estimates when
making predictions, particularly in elimination settings where infection data are sparse.
Recommendations
Due to the demonstrated uncertainty that knowledge gaps, particularly in the establishment of a
patent infection, can cause in estimating elimination thresholds it would be prudent to reﬁne the
evidence for these variables. Here we discuss a few options for future studies and analyses
that we believe could strengthen the knowledge base.
The probability that an infectious bite leads to an infectious host cannot be measured exper-
imentally in humans; however, we can improve current estimates with anecdotal and obser-
vational studies. Longitudinal studies can provide evidence of the time to antigen positivity
and the time to microﬁlaria positivity in children, or in adults that have moved from
nonendemic to endemic regions. One existing study, looking at acquisition in travelers,
surmises that the majority of cases are in individuals who spent in excess of 6 months in an
endemic region [49], whereas another cites a number of travelers contracting infection with
only 1 month of exposure [42]. Entomological studies routinely estimate ABR through
human landing catch data, and individual exposure can be quantiﬁed based on net usage
and vector biting habits [50,51].
The range of ABRs discussed are very broad estimates, covering a wide range of settings,
but this can be a difﬁcult variable to measure consistently. It may be possible to obtain greater
certainty in Re without accurate ABR measures for each location. For example, estimates of
low, medium, or high vector densities would still improve our predictions, and these categories
of exposure, which act as a proxy for R0 classiﬁcation, could be informed by a combination of
trap densities and vector-control coverage. Spatial heterogeneity can also occur within
implementation units, posing problems for any categorization process, so it is important that
treatment targets are determined by the maximum transmission measure for a region.
Concluding Remarks
We have used basic analyses to highlight that the existing experimental evidence does not afford
a high degree of certainty at the current 1% mf prevalence elimination threshold. This is mainly
because of uncertainties in variables which could be either experimentally or analytically reﬁned,
but also due to spatiotemporal variation in vector densities and biting rates [28]. That varying
the value of one input variable within sensible ranges found in the literature can make such an im-
pact on predictions, demonstrates the difﬁculties posed by targeting EOT when we know that
local heterogeneities and variability are difﬁcult to measure. Observations of ongoing transmissionFigure 4. Predicting Elimination Probabilities. Illustration of the potential impact of high uncertainty in variables by
considering their univariate impact on the probability of elimination (A) and the effective reproductive number (B) for the key
biological variables of the lymphatic ﬁlariasis (LF) transmission cycle, assuming a microﬁlaria (mf) prevalence of 1% and a
human population size of 1000. References for ranges of variables considered can be found in Table S1 in the
supplemental information online. Note that this univariate analysis should be interpreted carefully as variables are likely to
be correlated in ways which we cannot yet account for. For example, the mid-estimates here have been chosen to
represent a mid-ground of ranges found in the literature and are not necessarily representative of the true values or ranges
that may exist across real-world settings. Abbreviations: BFR, blood feeding rate; EIP, extrinsic incubation period.
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prompting some important outstanding policy questions (see Outstanding Questions).
In order to support efforts to eliminate LF we would recommend a multipronged approach:
improving the experimental evidence base of measurable quantities; detailed analysis
of existing infection data to improve our understanding of the infection risk associated
with an infectious bite; and development of a discrete system to classify vector density,
as a proxy for transmission intensity, to allow comparison of different regions. The optimiza-
tion of elimination programme strategies and surveillance will require continual revisiting
of predictions as we gather more epidemiological data through existing surveys and monitor-
ing infrastructures, as well as expanded epidemiological and surveillance studies at
low prevalence.
As more countries cease interventions and move to postvalidation surveillance it is increasingly
obvious that transmission breakpoints are unlikely to be one-size-ﬁts-all, hence more ﬂexible
thresholds are necessary. It is vital that we ensure that this process is well-informed, as prema-
turely halting control or surveillance programs could pose a serious threat to global targets, but
also because we believe that it may be possible to exploit this geographical variation to maximize
the probability of elimination.Acknowledgments
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